Gentile Kimberly

SVP, Clinical Operations, VP of Operations · SEC CIK 1704186
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$6.1M
20 trades
Net flow
−$6.1M
Net selling
Total filings
66
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Jan 7, 2026 ΔOwn +3.8%
+$0
3,750 sh
BHVN
Tax withholding Gentile Kimberly · SVP, Clinical Operations · Tax withholding · filed Jan 7, 2026 ΔOwn −1.9%
−$19.4K
1,956 sh @ $10
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Jan 7, 2025 ΔOwn +3.9%
+$0
3,750 sh
BHVN
Tax withholding Gentile Kimberly · SVP, Clinical Operations · Tax withholding · filed Jan 7, 2025 ΔOwn −2.0%
−$75.6K
1,956 sh @ $39
Advertisement
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +2.2%
+$2.5K
387 sh @ $6
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +69%
+$80.3K
12,612 sh @ $6
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +3.9%
+$5K
1,199 sh @ $4
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +43%
+$57K
13,801 sh @ $4
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +30%
+$39.8K
14,000 sh @ $3
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +5.0%
+$7.6K
3,000 sh @ $3
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +49%
+$49.8K
30,958 sh @ $2
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +1.6%
+$2.5K
1,542 sh @ $2
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +0.3%
+$304
295 sh @ $1
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +22%
+$21.3K
20,716 sh @ $1
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +3.9%
+$8.4K
4,500 sh @ $2
BHVN
Option exercise Gentile Kimberly · SVP, Clinical Operations · Option exercise · filed Oct 5, 2022 ΔOwn +10%
+$6.8K
12,500 sh @ $1
BHVN
Tax withholding Gentile Kimberly · SVP, Clinical Operations · Tax withholding · filed Oct 5, 2022 ΔOwn −28%
−$262.4K
37,492 sh @ $7

Frequently asked questions

How is Gentile Kimberly's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Gentile Kimberly's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.